nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CRABP1—germ cell cancer	0.416	1	CbGaD
Alitretinoin—peripheral nervous system neoplasm—germ cell cancer	0.392	1	CtDrD
Alitretinoin—ABCB1—Dactinomycin—germ cell cancer	0.00594	0.264	CbGbCtD
Alitretinoin—CYP1A2—Etoposide—germ cell cancer	0.00383	0.171	CbGbCtD
Alitretinoin—ABCB1—Vinblastine—germ cell cancer	0.00372	0.166	CbGbCtD
Alitretinoin—ABCB1—Cisplatin—germ cell cancer	0.00341	0.152	CbGbCtD
Alitretinoin—ABCB1—Etoposide—germ cell cancer	0.00335	0.149	CbGbCtD
Alitretinoin—CRABP2—Import of palmitoyl-CoA into the mitochondrial matrix—CRABP1—germ cell cancer	0.00307	0.0648	CbGpPWpGaD
Alitretinoin—CRABP2—Regulation of pyruvate dehydrogenase (PDH) complex—CRABP1—germ cell cancer	0.0026	0.0549	CbGpPWpGaD
Alitretinoin—ABCB1—Methotrexate—germ cell cancer	0.00221	0.0985	CbGbCtD
Alitretinoin—CRABP2—pineal body—germ cell cancer	0.00202	0.0468	CbGeAlD
Alitretinoin—Tretinoin—NR0B1—germ cell cancer	0.00188	0.591	CrCbGaD
Alitretinoin—CRABP2—Pyruvate metabolism—CRABP1—germ cell cancer	0.00188	0.0397	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptors—NR0B1—germ cell cancer	0.00185	0.0391	CbGpPWpGaD
Alitretinoin—CRABP2—skin epidermis—germ cell cancer	0.00172	0.0399	CbGeAlD
Alitretinoin—RXRG—Nuclear Receptors—NR0B1—germ cell cancer	0.00169	0.0357	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptors—NR0B1—germ cell cancer	0.00166	0.035	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptors—NR0B1—germ cell cancer	0.00159	0.0336	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptors—NR0B1—germ cell cancer	0.00159	0.0336	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00146	0.0309	CbGpPWpGaD
Alitretinoin—RXRA—ganglion—germ cell cancer	0.00144	0.0334	CbGeAlD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00134	0.0282	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00131	0.0277	CbGpPWpGaD
Alitretinoin—Tretinoin—CRABP1—germ cell cancer	0.0013	0.409	CrCbGaD
Alitretinoin—RXRG—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.0013	0.0274	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00126	0.0265	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00126	0.0265	CbGpPWpGaD
Alitretinoin—RXRB—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.00122	0.0257	CbGpPWpGaD
Alitretinoin—CRABP2—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.00118	0.0249	CbGpPWpGaD
Alitretinoin—CRABP2—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—germ cell cancer	0.00114	0.024	CbGpPWpGaD
Alitretinoin—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.000978	0.0207	CbGpPWpGaD
Alitretinoin—RXRA—Import of palmitoyl-CoA into the mitochondrial matrix—CRABP1—germ cell cancer	0.000929	0.0196	CbGpPWpGaD
Alitretinoin—CRABP1—neck—germ cell cancer	0.000911	0.0211	CbGeAlD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—CD9—germ cell cancer	0.000849	0.0179	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptors—NR0B1—germ cell cancer	0.000829	0.0175	CbGpPWpGaD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—CD9—germ cell cancer	0.000798	0.0168	CbGpPWpGaD
Alitretinoin—RARG—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000796	0.0168	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of pyruvate dehydrogenase (PDH) complex—CRABP1—germ cell cancer	0.000787	0.0166	CbGpPWpGaD
Alitretinoin—CRABP1—trigeminal ganglion—germ cell cancer	0.000786	0.0182	CbGeAlD
Alitretinoin—CRABP1—embryo—germ cell cancer	0.000759	0.0176	CbGeAlD
Alitretinoin—RXRG—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000728	0.0154	CbGpPWpGaD
Alitretinoin—RXRG—neck—germ cell cancer	0.00072	0.0167	CbGeAlD
Alitretinoin—RARB—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000714	0.0151	CbGpPWpGaD
Alitretinoin—CRABP2—trigeminal ganglion—germ cell cancer	0.000711	0.0165	CbGeAlD
Alitretinoin—CRABP1—brainstem—germ cell cancer	0.000696	0.0161	CbGeAlD
Alitretinoin—CRABP2—embryo—germ cell cancer	0.000687	0.0159	CbGeAlD
Alitretinoin—RXRB—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000685	0.0145	CbGpPWpGaD
Alitretinoin—RARA—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000685	0.0145	CbGpPWpGaD
Alitretinoin—CRABP1—eye—germ cell cancer	0.000677	0.0157	CbGeAlD
Alitretinoin—CRABP1—retina—germ cell cancer	0.000671	0.0156	CbGeAlD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000655	0.0138	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.000636	0.0134	CbGpPWpGaD
Alitretinoin—RXRG—trigeminal ganglion—germ cell cancer	0.000622	0.0144	CbGeAlD
Alitretinoin—CRABP2—eye—germ cell cancer	0.000613	0.0142	CbGeAlD
Alitretinoin—CRABP1—skin of body—germ cell cancer	0.000589	0.0137	CbGeAlD
Alitretinoin—RXRA—Pyruvate metabolism—CRABP1—germ cell cancer	0.000569	0.012	CbGpPWpGaD
Alitretinoin—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000562	0.0119	CbGpPWpGaD
Alitretinoin—RXRA—telencephalon—germ cell cancer	0.000556	0.0129	CbGeAlD
Alitretinoin—CYP1A2—urine—germ cell cancer	0.00054	0.0125	CbGeAlD
Alitretinoin—RXRG—eye—germ cell cancer	0.000536	0.0124	CbGeAlD
Alitretinoin—CRABP2—skin of body—germ cell cancer	0.000533	0.0124	CbGeAlD
Alitretinoin—CRABP2—decidua—germ cell cancer	0.000529	0.0123	CbGeAlD
Alitretinoin—RARG—trigeminal ganglion—germ cell cancer	0.000519	0.012	CbGeAlD
Alitretinoin—CRABP1—gonad—germ cell cancer	0.000515	0.012	CbGeAlD
Alitretinoin—CRABP1—pituitary gland—germ cell cancer	0.000503	0.0117	CbGeAlD
Alitretinoin—CRABP1—medulla oblongata—germ cell cancer	0.000485	0.0113	CbGeAlD
Alitretinoin—CRABP2—gonad—germ cell cancer	0.000466	0.0108	CbGeAlD
Alitretinoin—RXRB—telencephalon—germ cell cancer	0.000459	0.0106	CbGeAlD
Alitretinoin—CRABP2—pituitary gland—germ cell cancer	0.000455	0.0105	CbGeAlD
Alitretinoin—RARG—eye—germ cell cancer	0.000447	0.0104	CbGeAlD
Alitretinoin—CRABP1—midbrain—germ cell cancer	0.000444	0.0103	CbGeAlD
Alitretinoin—RARG—retina—germ cell cancer	0.000443	0.0103	CbGeAlD
Alitretinoin—CRABP2—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—germ cell cancer	0.000441	0.00931	CbGpPWpGaD
Alitretinoin—CRABP2—medulla oblongata—germ cell cancer	0.000439	0.0102	CbGeAlD
Alitretinoin—RXRB—decidua—germ cell cancer	0.000435	0.0101	CbGeAlD
Alitretinoin—CRABP1—spinal cord—germ cell cancer	0.000433	0.01	CbGeAlD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—CD9—germ cell cancer	0.000416	0.00878	CbGpPWpGaD
Alitretinoin—CRABP2—adrenal gland—germ cell cancer	0.000406	0.00942	CbGeAlD
Alitretinoin—RXRG—pituitary gland—germ cell cancer	0.000397	0.00922	CbGeAlD
Alitretinoin—CRABP2—spinal cord—germ cell cancer	0.000391	0.00908	CbGeAlD
Alitretinoin—CRABP1—endocrine gland—germ cell cancer	0.00039	0.00904	CbGeAlD
Alitretinoin—RARG—skin of body—germ cell cancer	0.000389	0.00902	CbGeAlD
Alitretinoin—RARG—decidua—germ cell cancer	0.000386	0.00896	CbGeAlD
Alitretinoin—CRABP1—head—germ cell cancer	0.000385	0.00892	CbGeAlD
Alitretinoin—RXRG—medulla oblongata—germ cell cancer	0.000384	0.0089	CbGeAlD
Alitretinoin—RARA—telencephalon—germ cell cancer	0.000383	0.00889	CbGeAlD
Alitretinoin—CRABP2—female gonad—germ cell cancer	0.000379	0.00879	CbGeAlD
Alitretinoin—RXRA—female gonad—germ cell cancer	0.000377	0.00875	CbGeAlD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.000375	0.00791	CbGpPWpGaD
Alitretinoin—CRABP1—testis—germ cell cancer	0.000372	0.00862	CbGeAlD
Alitretinoin—RARB—adrenal gland—germ cell cancer	0.000363	0.00843	CbGeAlD
Alitretinoin—RARA—decidua—germ cell cancer	0.000363	0.00842	CbGeAlD
Alitretinoin—RXRA—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	0.000357	0.00753	CbGpPWpGaD
Alitretinoin—RXRG—adrenal gland—germ cell cancer	0.000355	0.00824	CbGeAlD
Alitretinoin—CRABP2—endocrine gland—germ cell cancer	0.000352	0.00817	CbGeAlD
Alitretinoin—RXRA—endocrine gland—germ cell cancer	0.000351	0.00814	CbGeAlD
Alitretinoin—RXRG—midbrain—germ cell cancer	0.000351	0.00813	CbGeAlD
Alitretinoin—CRABP2—head—germ cell cancer	0.000348	0.00807	CbGeAlD
Alitretinoin—RXRA—head—germ cell cancer	0.000346	0.00803	CbGeAlD
Alitretinoin—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—germ cell cancer	0.000344	0.00726	CbGpPWpGaD
Alitretinoin—CRABP1—cerebellum—germ cell cancer	0.000343	0.00796	CbGeAlD
Alitretinoin—RXRG—spinal cord—germ cell cancer	0.000342	0.00794	CbGeAlD
Alitretinoin—RARB—female gonad—germ cell cancer	0.000339	0.00786	CbGeAlD
Alitretinoin—RARG—uterus—germ cell cancer	0.000338	0.00784	CbGeAlD
Alitretinoin—CRABP2—testis—germ cell cancer	0.000336	0.00779	CbGeAlD
Alitretinoin—RXRB—adrenal gland—germ cell cancer	0.000334	0.00775	CbGeAlD
Alitretinoin—RARA—gonad—germ cell cancer	0.00032	0.00742	CbGeAlD
Alitretinoin—RARA—uterus—germ cell cancer	0.000318	0.00737	CbGeAlD
Alitretinoin—RARB—endocrine gland—germ cell cancer	0.000315	0.00731	CbGeAlD
Alitretinoin—RARA—pituitary gland—germ cell cancer	0.000312	0.00724	CbGeAlD
Alitretinoin—RXRB—female gonad—germ cell cancer	0.000311	0.00722	CbGeAlD
Alitretinoin—RARB—head—germ cell cancer	0.000311	0.00722	CbGeAlD
Alitretinoin—CRABP2—cerebellum—germ cell cancer	0.00031	0.0072	CbGeAlD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—KLF4—germ cell cancer	0.00031	0.00654	CbGpPWpGaD
Alitretinoin—RXRG—endocrine gland—germ cell cancer	0.000308	0.00714	CbGeAlD
Alitretinoin—RXRG—head—germ cell cancer	0.000304	0.00705	CbGeAlD
Alitretinoin—RARG—adrenal gland—germ cell cancer	0.000296	0.00688	CbGeAlD
Alitretinoin—RXRG—testis—germ cell cancer	0.000294	0.00681	CbGeAlD
Alitretinoin—RXRB—endocrine gland—germ cell cancer	0.00029	0.00672	CbGeAlD
Alitretinoin—RXRB—head—germ cell cancer	0.000286	0.00663	CbGeAlD
Alitretinoin—CRABP1—brain—germ cell cancer	0.000279	0.00647	CbGeAlD
Alitretinoin—RARA—adrenal gland—germ cell cancer	0.000279	0.00646	CbGeAlD
Alitretinoin—RARB—cerebellum—germ cell cancer	0.000277	0.00644	CbGeAlD
Alitretinoin—RARG—female gonad—germ cell cancer	0.000276	0.00641	CbGeAlD
Alitretinoin—RXRB—testis—germ cell cancer	0.000276	0.00641	CbGeAlD
Alitretinoin—RARA—bone marrow—germ cell cancer	0.00027	0.00625	CbGeAlD
Alitretinoin—RARA—female gonad—germ cell cancer	0.00026	0.00603	CbGeAlD
Alitretinoin—RXRB—cerebellum—germ cell cancer	0.000255	0.00592	CbGeAlD
Alitretinoin—RARG—head—germ cell cancer	0.000254	0.00589	CbGeAlD
Alitretinoin—RARG—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000253	0.00533	CbGpPWpGaD
Alitretinoin—CRABP2—brain—germ cell cancer	0.000252	0.00585	CbGeAlD
Alitretinoin—RXRA—brain—germ cell cancer	0.000251	0.00582	CbGeAlD
Alitretinoin—RARG—testis—germ cell cancer	0.000245	0.00569	CbGeAlD
Alitretinoin—RARA—endocrine gland—germ cell cancer	0.000242	0.00561	CbGeAlD
Alitretinoin—RARA—head—germ cell cancer	0.000239	0.00553	CbGeAlD
Alitretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—germ cell cancer	0.000231	0.00488	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000231	0.00488	CbGpPWpGaD
Alitretinoin—RARA—testis—germ cell cancer	0.00023	0.00535	CbGeAlD
Alitretinoin—RARB—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000227	0.00478	CbGpPWpGaD
Alitretinoin—RARG—cerebellum—germ cell cancer	0.000226	0.00525	CbGeAlD
Alitretinoin—RARB—brain—germ cell cancer	0.000225	0.00523	CbGeAlD
Alitretinoin—RXRG—brain—germ cell cancer	0.00022	0.00511	CbGeAlD
Alitretinoin—RARB—lymph node—germ cell cancer	0.000218	0.00505	CbGeAlD
Alitretinoin—RXRB—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000217	0.00458	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000217	0.00458	CbGpPWpGaD
Alitretinoin—RARA—cerebellum—germ cell cancer	0.000213	0.00494	CbGeAlD
Alitretinoin—RXRB—brain—germ cell cancer	0.000207	0.00481	CbGeAlD
Alitretinoin—RARG—brain—germ cell cancer	0.000184	0.00427	CbGeAlD
Alitretinoin—RARG—lymph node—germ cell cancer	0.000178	0.00412	CbGeAlD
Alitretinoin—RARA—brain—germ cell cancer	0.000173	0.00401	CbGeAlD
Alitretinoin—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	0.00017	0.00358	CbGpPWpGaD
Alitretinoin—RXRA—Circadian Clock—AVP—germ cell cancer	0.000168	0.00355	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—SLC2A3—germ cell cancer	0.000167	0.00353	CbGpPWpGaD
Alitretinoin—RARA—lymph node—germ cell cancer	0.000167	0.00387	CbGeAlD
Alitretinoin—ABCB1—blood vessel—germ cell cancer	0.00015	0.00348	CbGeAlD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000149	0.00315	CbGpPWpGaD
Alitretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—germ cell cancer	0.000133	0.00282	CbGpPWpGaD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	0.000122	0.00257	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NR0B1—germ cell cancer	0.000122	0.00257	CbGpPWpGaD
Alitretinoin—RXRA—PPAR Alpha Pathway—MYC—germ cell cancer	0.000118	0.00249	CbGpPWpGaD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	0.000114	0.00242	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.000114	0.0024	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TDGF1—germ cell cancer	0.000113	0.00239	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000113	0.00239	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NR0B1—germ cell cancer	0.000111	0.00235	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NR0B1—germ cell cancer	0.000109	0.0023	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—DNMT3L—germ cell cancer	0.000105	0.00223	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NR0B1—germ cell cancer	0.000105	0.00221	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NR0B1—germ cell cancer	0.000105	0.00221	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—RARS—germ cell cancer	9.8e-05	0.00207	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—DNMT3L—germ cell cancer	9.64e-05	0.00204	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—SALL4—germ cell cancer	9.64e-05	0.00203	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—DNMT3L—germ cell cancer	9.46e-05	0.002	CbGpPWpGaD
Alitretinoin—ABCB1—trigeminal ganglion—germ cell cancer	9.27e-05	0.00215	CbGeAlD
Alitretinoin—RXRA—Developmental Biology—NANOG—germ cell cancer	9.24e-05	0.00195	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—DNMT3L—germ cell cancer	9.07e-05	0.00191	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—DNMT3L—germ cell cancer	9.07e-05	0.00191	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—RARS—germ cell cancer	8.97e-05	0.00189	CbGpPWpGaD
Alitretinoin—CYP1A2—endocrine gland—germ cell cancer	8.96e-05	0.00208	CbGeAlD
Alitretinoin—ABCB1—embryo—germ cell cancer	8.95e-05	0.00208	CbGeAlD
Alitretinoin—RXRA—Developmental Biology—POU5F1—germ cell cancer	8.89e-05	0.00188	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—RARS—germ cell cancer	8.79e-05	0.00186	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—RARS—germ cell cancer	8.43e-05	0.00178	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—RARS—germ cell cancer	8.43e-05	0.00178	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—SLC2A3—germ cell cancer	8.28e-05	0.00175	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—SLC2A3—germ cell cancer	8.28e-05	0.00175	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	8.18e-05	0.00173	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—SLC22A3—germ cell cancer	8.16e-05	0.00172	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—SLC22A3—germ cell cancer	8.16e-05	0.00172	CbGpPWpGaD
Alitretinoin—ABCB1—retina—germ cell cancer	7.91e-05	0.00184	CbGeAlD
Alitretinoin—ABCB1—telencephalon—germ cell cancer	7.28e-05	0.00169	CbGeAlD
Alitretinoin—RXRA—Developmental Biology—KLF4—germ cell cancer	7e-05	0.00148	CbGpPWpGaD
Alitretinoin—ABCB1—decidua—germ cell cancer	6.9e-05	0.0016	CbGeAlD
Alitretinoin—CRABP2—Metabolism—CRABP1—germ cell cancer	6.65e-05	0.0014	CbGpPWpGaD
Alitretinoin—Erythema multiforme—Etoposide—germ cell cancer	6.25e-05	0.000822	CcSEcCtD
Alitretinoin—Paraesthesia—Bleomycin—germ cell cancer	6.24e-05	0.000822	CcSEcCtD
Alitretinoin—Dyspnoea—Bleomycin—germ cell cancer	6.2e-05	0.000816	CcSEcCtD
Alitretinoin—Arthralgia—Ifosfamide—germ cell cancer	6.2e-05	0.000816	CcSEcCtD
Alitretinoin—Myalgia—Ifosfamide—germ cell cancer	6.2e-05	0.000816	CcSEcCtD
Alitretinoin—Chest pain—Ifosfamide—germ cell cancer	6.2e-05	0.000816	CcSEcCtD
Alitretinoin—Renal failure acute—Methotrexate—germ cell cancer	6.19e-05	0.000816	CcSEcCtD
Alitretinoin—Flatulence—Cisplatin—germ cell cancer	6.18e-05	0.000814	CcSEcCtD
Alitretinoin—Anorexia—Dactinomycin—germ cell cancer	6.18e-05	0.000814	CcSEcCtD
Alitretinoin—Eye disorder—Etoposide—germ cell cancer	6.17e-05	0.000813	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	6.16e-05	0.000811	CcSEcCtD
Alitretinoin—Flushing—Etoposide—germ cell cancer	6.13e-05	0.000807	CcSEcCtD
Alitretinoin—Discomfort—Ifosfamide—germ cell cancer	6.12e-05	0.000806	CcSEcCtD
Alitretinoin—ABCB1—gonad—germ cell cancer	6.07e-05	0.00141	CbGeAlD
Alitretinoin—Hypersensitivity—Vinblastine—germ cell cancer	6.06e-05	0.000799	CcSEcCtD
Alitretinoin—Dermatitis exfoliative—Methotrexate—germ cell cancer	6.06e-05	0.000798	CcSEcCtD
Alitretinoin—Decreased appetite—Bleomycin—germ cell cancer	6.04e-05	0.000796	CcSEcCtD
Alitretinoin—Visual disturbance—Methotrexate—germ cell cancer	6.04e-05	0.000795	CcSEcCtD
Alitretinoin—ABCB1—uterus—germ cell cancer	6.03e-05	0.0014	CbGeAlD
Alitretinoin—Angiopathy—Etoposide—germ cell cancer	5.99e-05	0.000789	CcSEcCtD
Alitretinoin—Confusional state—Ifosfamide—germ cell cancer	5.99e-05	0.000789	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	5.96e-05	0.00126	CbGpPWpGaD
Alitretinoin—Pain—Bleomycin—germ cell cancer	5.95e-05	0.000783	CcSEcCtD
Alitretinoin—Anaphylactic shock—Ifosfamide—germ cell cancer	5.94e-05	0.000782	CcSEcCtD
Alitretinoin—Oedema—Ifosfamide—germ cell cancer	5.94e-05	0.000782	CcSEcCtD
Alitretinoin—Chills—Etoposide—germ cell cancer	5.93e-05	0.00078	CcSEcCtD
Alitretinoin—ABCB1—pituitary gland—germ cell cancer	5.93e-05	0.00137	CbGeAlD
Alitretinoin—Vision blurred—Cisplatin—germ cell cancer	5.92e-05	0.000779	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	5.91e-05	0.000778	CcSEcCtD
Alitretinoin—Asthenia—Vinblastine—germ cell cancer	5.91e-05	0.000778	CcSEcCtD
Alitretinoin—Infection—Ifosfamide—germ cell cancer	5.9e-05	0.000777	CcSEcCtD
Alitretinoin—Tremor—Cisplatin—germ cell cancer	5.88e-05	0.000774	CcSEcCtD
Alitretinoin—Alopecia—Etoposide—germ cell cancer	5.84e-05	0.000769	CcSEcCtD
Alitretinoin—Cerebrovascular accident—Methotrexate—germ cell cancer	5.84e-05	0.000768	CcSEcCtD
Alitretinoin—Lethargy—Methotrexate—germ cell cancer	5.84e-05	0.000768	CcSEcCtD
Alitretinoin—Nervous system disorder—Ifosfamide—germ cell cancer	5.83e-05	0.000767	CcSEcCtD
Alitretinoin—Ill-defined disorder—Cisplatin—germ cell cancer	5.82e-05	0.000767	CcSEcCtD
Alitretinoin—Thrombocytopenia—Ifosfamide—germ cell cancer	5.82e-05	0.000766	CcSEcCtD
Alitretinoin—Anaemia—Cisplatin—germ cell cancer	5.8e-05	0.000764	CcSEcCtD
Alitretinoin—Skin disorder—Ifosfamide—germ cell cancer	5.77e-05	0.00076	CcSEcCtD
Alitretinoin—Hyperhidrosis—Ifosfamide—germ cell cancer	5.74e-05	0.000756	CcSEcCtD
Alitretinoin—Feeling abnormal—Bleomycin—germ cell cancer	5.73e-05	0.000754	CcSEcCtD
Alitretinoin—Osteoarthritis—Methotrexate—germ cell cancer	5.72e-05	0.000753	CcSEcCtD
Alitretinoin—ABCB1—medulla oblongata—germ cell cancer	5.72e-05	0.00133	CbGeAlD
Alitretinoin—Anorexia—Ifosfamide—germ cell cancer	5.66e-05	0.000746	CcSEcCtD
Alitretinoin—Malaise—Cisplatin—germ cell cancer	5.66e-05	0.000745	CcSEcCtD
Alitretinoin—Decreased appetite—Dactinomycin—germ cell cancer	5.64e-05	0.000742	CcSEcCtD
Alitretinoin—Diarrhoea—Vinblastine—germ cell cancer	5.63e-05	0.000742	CcSEcCtD
Alitretinoin—Fatigue—Dactinomycin—germ cell cancer	5.59e-05	0.000736	CcSEcCtD
Alitretinoin—Back pain—Etoposide—germ cell cancer	5.56e-05	0.000732	CcSEcCtD
Alitretinoin—Hypotension—Ifosfamide—germ cell cancer	5.55e-05	0.000731	CcSEcCtD
Alitretinoin—Pain—Dactinomycin—germ cell cancer	5.54e-05	0.00073	CcSEcCtD
Alitretinoin—Urticaria—Bleomycin—germ cell cancer	5.52e-05	0.000727	CcSEcCtD
Alitretinoin—Body temperature increased—Bleomycin—germ cell cancer	5.5e-05	0.000724	CcSEcCtD
Alitretinoin—Irritability—Methotrexate—germ cell cancer	5.46e-05	0.000719	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—NR0B1—germ cell cancer	5.45e-05	0.00115	CbGpPWpGaD
Alitretinoin—Dizziness—Vinblastine—germ cell cancer	5.44e-05	0.000717	CcSEcCtD
Alitretinoin—Convulsion—Cisplatin—germ cell cancer	5.44e-05	0.000716	CcSEcCtD
Alitretinoin—Mood swings—Methotrexate—germ cell cancer	5.42e-05	0.000713	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	5.41e-05	0.000713	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.35e-05	0.00113	CbGpPWpGaD
Alitretinoin—Myalgia—Cisplatin—germ cell cancer	5.34e-05	0.000704	CcSEcCtD
Alitretinoin—Feeling abnormal—Dactinomycin—germ cell cancer	5.34e-05	0.000704	CcSEcCtD
Alitretinoin—Paraesthesia—Ifosfamide—germ cell cancer	5.34e-05	0.000703	CcSEcCtD
Alitretinoin—Ill-defined disorder—Etoposide—germ cell cancer	5.34e-05	0.000702	CcSEcCtD
Alitretinoin—Anxiety—Cisplatin—germ cell cancer	5.33e-05	0.000701	CcSEcCtD
Alitretinoin—Anaemia—Etoposide—germ cell cancer	5.31e-05	0.0007	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	5.31e-05	0.000699	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Dactinomycin—germ cell cancer	5.3e-05	0.000698	CcSEcCtD
Alitretinoin—Dyspnoea—Ifosfamide—germ cell cancer	5.3e-05	0.000698	CcSEcCtD
Alitretinoin—ABCB1—adrenal gland—germ cell cancer	5.29e-05	0.00123	CbGeAlD
Alitretinoin—Somnolence—Ifosfamide—germ cell cancer	5.28e-05	0.000696	CcSEcCtD
Alitretinoin—Discomfort—Cisplatin—germ cell cancer	5.28e-05	0.000695	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.27e-05	0.00111	CbGpPWpGaD
Alitretinoin—Vomiting—Vinblastine—germ cell cancer	5.23e-05	0.000689	CcSEcCtD
Alitretinoin—ABCB1—midbrain—germ cell cancer	5.23e-05	0.00121	CbGeAlD
Alitretinoin—Malaise—Etoposide—germ cell cancer	5.19e-05	0.000683	CcSEcCtD
Alitretinoin—Decreased appetite—Ifosfamide—germ cell cancer	5.17e-05	0.00068	CcSEcCtD
Alitretinoin—Headache—Vinblastine—germ cell cancer	5.16e-05	0.000679	CcSEcCtD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	5.15e-05	0.00109	CbGpPWpGaD
Alitretinoin—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	5.15e-05	0.000678	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Ifosfamide—germ cell cancer	5.13e-05	0.000675	CcSEcCtD
Alitretinoin—Abdominal pain—Dactinomycin—germ cell cancer	5.13e-05	0.000675	CcSEcCtD
Alitretinoin—Body temperature increased—Dactinomycin—germ cell cancer	5.13e-05	0.000675	CcSEcCtD
Alitretinoin—Fatigue—Ifosfamide—germ cell cancer	5.12e-05	0.000675	CcSEcCtD
Alitretinoin—Anaphylactic shock—Cisplatin—germ cell cancer	5.12e-05	0.000674	CcSEcCtD
Alitretinoin—Oedema—Cisplatin—germ cell cancer	5.12e-05	0.000674	CcSEcCtD
Alitretinoin—Hypersensitivity—Bleomycin—germ cell cancer	5.12e-05	0.000674	CcSEcCtD
Alitretinoin—ABCB1—bone marrow—germ cell cancer	5.12e-05	0.00119	CbGeAlD
Alitretinoin—ABCB1—spinal cord—germ cell cancer	5.1e-05	0.00118	CbGeAlD
Alitretinoin—Infection—Cisplatin—germ cell cancer	5.09e-05	0.00067	CcSEcCtD
Alitretinoin—Pain—Ifosfamide—germ cell cancer	5.08e-05	0.000669	CcSEcCtD
Alitretinoin—Constipation—Ifosfamide—germ cell cancer	5.08e-05	0.000669	CcSEcCtD
Alitretinoin—Loss of consciousness—Etoposide—germ cell cancer	5.05e-05	0.000665	CcSEcCtD
Alitretinoin—Nervous system disorder—Cisplatin—germ cell cancer	5.02e-05	0.000661	CcSEcCtD
Alitretinoin—Cough—Etoposide—germ cell cancer	5.02e-05	0.000661	CcSEcCtD
Alitretinoin—Thrombocytopenia—Cisplatin—germ cell cancer	5.02e-05	0.00066	CcSEcCtD
Alitretinoin—Tachycardia—Cisplatin—germ cell cancer	5e-05	0.000658	CcSEcCtD
Alitretinoin—Asthenia—Bleomycin—germ cell cancer	4.99e-05	0.000657	CcSEcCtD
Alitretinoin—Convulsion—Etoposide—germ cell cancer	4.98e-05	0.000656	CcSEcCtD
Alitretinoin—Skin disorder—Cisplatin—germ cell cancer	4.98e-05	0.000655	CcSEcCtD
Alitretinoin—Hypertension—Etoposide—germ cell cancer	4.96e-05	0.000654	CcSEcCtD
Alitretinoin—Hyperhidrosis—Cisplatin—germ cell cancer	4.95e-05	0.000652	CcSEcCtD
Alitretinoin—Asthma—Methotrexate—germ cell cancer	4.94e-05	0.000651	CcSEcCtD
Alitretinoin—ABCB1—female gonad—germ cell cancer	4.94e-05	0.00114	CbGeAlD
Alitretinoin—RXRA—Developmental Biology—SOX2—germ cell cancer	4.93e-05	0.00104	CbGpPWpGaD
Alitretinoin—Pruritus—Bleomycin—germ cell cancer	4.92e-05	0.000648	CcSEcCtD
Alitretinoin—Feeling abnormal—Ifosfamide—germ cell cancer	4.9e-05	0.000645	CcSEcCtD
Alitretinoin—Chest pain—Etoposide—germ cell cancer	4.9e-05	0.000645	CcSEcCtD
Alitretinoin—Nausea—Vinblastine—germ cell cancer	4.89e-05	0.000644	CcSEcCtD
Alitretinoin—Anorexia—Cisplatin—germ cell cancer	4.88e-05	0.000643	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	4.86e-05	0.00064	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Ifosfamide—germ cell cancer	4.86e-05	0.00064	CcSEcCtD
Alitretinoin—Pancreatitis—Methotrexate—germ cell cancer	4.85e-05	0.000638	CcSEcCtD
Alitretinoin—Discomfort—Etoposide—germ cell cancer	4.84e-05	0.000637	CcSEcCtD
Alitretinoin—Hypotension—Cisplatin—germ cell cancer	4.79e-05	0.00063	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	4.78e-05	0.00101	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Dactinomycin—germ cell cancer	4.78e-05	0.000629	CcSEcCtD
Alitretinoin—Abdominal discomfort—Methotrexate—germ cell cancer	4.74e-05	0.000624	CcSEcCtD
Alitretinoin—Confusional state—Etoposide—germ cell cancer	4.73e-05	0.000623	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—DNMT3L—germ cell cancer	4.73e-05	0.000997	CbGpPWpGaD
Alitretinoin—Urticaria—Ifosfamide—germ cell cancer	4.72e-05	0.000622	CcSEcCtD
Alitretinoin—Body temperature increased—Ifosfamide—germ cell cancer	4.7e-05	0.000618	CcSEcCtD
Alitretinoin—Abdominal pain—Ifosfamide—germ cell cancer	4.7e-05	0.000618	CcSEcCtD
Alitretinoin—Anaphylactic shock—Etoposide—germ cell cancer	4.69e-05	0.000618	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	4.67e-05	0.000615	CcSEcCtD
Alitretinoin—Infection—Etoposide—germ cell cancer	4.66e-05	0.000614	CcSEcCtD
Alitretinoin—Asthenia—Dactinomycin—germ cell cancer	4.65e-05	0.000613	CcSEcCtD
Alitretinoin—Dysuria—Methotrexate—germ cell cancer	4.62e-05	0.000609	CcSEcCtD
Alitretinoin—Neutropenia—Methotrexate—germ cell cancer	4.62e-05	0.000609	CcSEcCtD
Alitretinoin—Paraesthesia—Cisplatin—germ cell cancer	4.6e-05	0.000606	CcSEcCtD
Alitretinoin—Thrombocytopenia—Etoposide—germ cell cancer	4.59e-05	0.000605	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Methotrexate—germ cell cancer	4.59e-05	0.000605	CcSEcCtD
Alitretinoin—ABCB1—endocrine gland—germ cell cancer	4.59e-05	0.00106	CbGeAlD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	4.58e-05	0.000967	CbGpPWpGaD
Alitretinoin—Tachycardia—Etoposide—germ cell cancer	4.58e-05	0.000603	CcSEcCtD
Alitretinoin—Dyspnoea—Cisplatin—germ cell cancer	4.57e-05	0.000601	CcSEcCtD
Alitretinoin—Skin disorder—Etoposide—germ cell cancer	4.56e-05	0.0006	CcSEcCtD
Alitretinoin—Hyperhidrosis—Etoposide—germ cell cancer	4.54e-05	0.000597	CcSEcCtD
Alitretinoin—ABCB1—head—germ cell cancer	4.53e-05	0.00105	CbGeAlD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.52e-05	0.000954	CbGpPWpGaD
Alitretinoin—Photosensitivity reaction—Methotrexate—germ cell cancer	4.51e-05	0.000594	CcSEcCtD
Alitretinoin—Anorexia—Etoposide—germ cell cancer	4.47e-05	0.000589	CcSEcCtD
Alitretinoin—Decreased appetite—Cisplatin—germ cell cancer	4.45e-05	0.000586	CcSEcCtD
Alitretinoin—Diarrhoea—Dactinomycin—germ cell cancer	4.44e-05	0.000584	CcSEcCtD
Alitretinoin—Pneumonia—Methotrexate—germ cell cancer	4.43e-05	0.000584	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Cisplatin—germ cell cancer	4.42e-05	0.000582	CcSEcCtD
Alitretinoin—Vomiting—Bleomycin—germ cell cancer	4.42e-05	0.000582	CcSEcCtD
Alitretinoin—Infestation NOS—Methotrexate—germ cell cancer	4.41e-05	0.00058	CcSEcCtD
Alitretinoin—Infestation—Methotrexate—germ cell cancer	4.41e-05	0.00058	CcSEcCtD
Alitretinoin—Drowsiness—Methotrexate—germ cell cancer	4.41e-05	0.00058	CcSEcCtD
Alitretinoin—Depression—Methotrexate—germ cell cancer	4.39e-05	0.000579	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—RARS—germ cell cancer	4.39e-05	0.000927	CbGpPWpGaD
Alitretinoin—Hypotension—Etoposide—germ cell cancer	4.39e-05	0.000577	CcSEcCtD
Alitretinoin—Rash—Bleomycin—germ cell cancer	4.38e-05	0.000577	CcSEcCtD
Alitretinoin—Pain—Cisplatin—germ cell cancer	4.38e-05	0.000577	CcSEcCtD
Alitretinoin—Dermatitis—Bleomycin—germ cell cancer	4.38e-05	0.000577	CcSEcCtD
Alitretinoin—Hypersensitivity—Ifosfamide—germ cell cancer	4.38e-05	0.000576	CcSEcCtD
Alitretinoin—ABCB1—testis—germ cell cancer	4.38e-05	0.00102	CbGeAlD
Alitretinoin—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	4.37e-05	0.000575	CcSEcCtD
Alitretinoin—Renal failure—Methotrexate—germ cell cancer	4.33e-05	0.00057	CcSEcCtD
Alitretinoin—Stomatitis—Methotrexate—germ cell cancer	4.3e-05	0.000566	CcSEcCtD
Alitretinoin—Conjunctivitis—Methotrexate—germ cell cancer	4.28e-05	0.000564	CcSEcCtD
Alitretinoin—Asthenia—Ifosfamide—germ cell cancer	4.26e-05	0.000561	CcSEcCtD
Alitretinoin—Sweating—Methotrexate—germ cell cancer	4.23e-05	0.000556	CcSEcCtD
Alitretinoin—Feeling abnormal—Cisplatin—germ cell cancer	4.22e-05	0.000556	CcSEcCtD
Alitretinoin—Paraesthesia—Etoposide—germ cell cancer	4.21e-05	0.000555	CcSEcCtD
Alitretinoin—Pruritus—Ifosfamide—germ cell cancer	4.2e-05	0.000554	CcSEcCtD
Alitretinoin—Haematuria—Methotrexate—germ cell cancer	4.2e-05	0.000553	CcSEcCtD
Alitretinoin—Dyspnoea—Etoposide—germ cell cancer	4.18e-05	0.000551	CcSEcCtD
Alitretinoin—Somnolence—Etoposide—germ cell cancer	4.17e-05	0.000549	CcSEcCtD
Alitretinoin—Epistaxis—Methotrexate—germ cell cancer	4.16e-05	0.000547	CcSEcCtD
Alitretinoin—Nausea—Bleomycin—germ cell cancer	4.13e-05	0.000544	CcSEcCtD
Alitretinoin—Vomiting—Dactinomycin—germ cell cancer	4.12e-05	0.000543	CcSEcCtD
Alitretinoin—Agranulocytosis—Methotrexate—germ cell cancer	4.11e-05	0.000542	CcSEcCtD
Alitretinoin—Rash—Dactinomycin—germ cell cancer	4.09e-05	0.000538	CcSEcCtD
Alitretinoin—Decreased appetite—Etoposide—germ cell cancer	4.08e-05	0.000537	CcSEcCtD
Alitretinoin—Diarrhoea—Ifosfamide—germ cell cancer	4.07e-05	0.000535	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Etoposide—germ cell cancer	4.05e-05	0.000533	CcSEcCtD
Alitretinoin—Body temperature increased—Cisplatin—germ cell cancer	4.05e-05	0.000533	CcSEcCtD
Alitretinoin—Fatigue—Etoposide—germ cell cancer	4.05e-05	0.000533	CcSEcCtD
Alitretinoin—ABCB1—cerebellum—germ cell cancer	4.04e-05	0.000938	CbGeAlD
Alitretinoin—Pain—Etoposide—germ cell cancer	4.01e-05	0.000528	CcSEcCtD
Alitretinoin—Constipation—Etoposide—germ cell cancer	4.01e-05	0.000528	CcSEcCtD
Alitretinoin—Haemoglobin—Methotrexate—germ cell cancer	3.98e-05	0.000524	CcSEcCtD
Alitretinoin—Haemorrhage—Methotrexate—germ cell cancer	3.96e-05	0.000521	CcSEcCtD
Alitretinoin—Hepatitis—Methotrexate—germ cell cancer	3.96e-05	0.000521	CcSEcCtD
Alitretinoin—Dizziness—Ifosfamide—germ cell cancer	3.93e-05	0.000517	CcSEcCtD
Alitretinoin—Pharyngitis—Methotrexate—germ cell cancer	3.93e-05	0.000517	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.93e-05	0.000829	CbGpPWpGaD
Alitretinoin—Urinary tract disorder—Methotrexate—germ cell cancer	3.91e-05	0.000514	CcSEcCtD
Alitretinoin—Urethral disorder—Methotrexate—germ cell cancer	3.88e-05	0.000511	CcSEcCtD
Alitretinoin—Feeling abnormal—Etoposide—germ cell cancer	3.87e-05	0.000509	CcSEcCtD
Alitretinoin—Nausea—Dactinomycin—germ cell cancer	3.85e-05	0.000507	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Etoposide—germ cell cancer	3.84e-05	0.000505	CcSEcCtD
Alitretinoin—Visual impairment—Methotrexate—germ cell cancer	3.81e-05	0.000502	CcSEcCtD
Alitretinoin—Vomiting—Ifosfamide—germ cell cancer	3.78e-05	0.000497	CcSEcCtD
Alitretinoin—Hypersensitivity—Cisplatin—germ cell cancer	3.77e-05	0.000497	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.76e-05	0.000794	CbGpPWpGaD
Alitretinoin—Rash—Ifosfamide—germ cell cancer	3.75e-05	0.000493	CcSEcCtD
Alitretinoin—Dermatitis—Ifosfamide—germ cell cancer	3.74e-05	0.000493	CcSEcCtD
Alitretinoin—Erythema multiforme—Methotrexate—germ cell cancer	3.74e-05	0.000493	CcSEcCtD
Alitretinoin—Urticaria—Etoposide—germ cell cancer	3.73e-05	0.000491	CcSEcCtD
Alitretinoin—Abdominal pain—Etoposide—germ cell cancer	3.71e-05	0.000488	CcSEcCtD
Alitretinoin—Body temperature increased—Etoposide—germ cell cancer	3.71e-05	0.000488	CcSEcCtD
Alitretinoin—Eye disorder—Methotrexate—germ cell cancer	3.7e-05	0.000487	CcSEcCtD
Alitretinoin—RARG—Gene Expression—H2AFZ—germ cell cancer	3.69e-05	0.000779	CbGpPWpGaD
Alitretinoin—Tinnitus—Methotrexate—germ cell cancer	3.69e-05	0.000486	CcSEcCtD
Alitretinoin—Asthenia—Cisplatin—germ cell cancer	3.68e-05	0.000484	CcSEcCtD
Alitretinoin—Angiopathy—Methotrexate—germ cell cancer	3.59e-05	0.000473	CcSEcCtD
Alitretinoin—Chills—Methotrexate—germ cell cancer	3.55e-05	0.000467	CcSEcCtD
Alitretinoin—Nausea—Ifosfamide—germ cell cancer	3.53e-05	0.000465	CcSEcCtD
Alitretinoin—Diarrhoea—Cisplatin—germ cell cancer	3.5e-05	0.000461	CcSEcCtD
Alitretinoin—Alopecia—Methotrexate—germ cell cancer	3.5e-05	0.00046	CcSEcCtD
Alitretinoin—Mental disorder—Methotrexate—germ cell cancer	3.47e-05	0.000456	CcSEcCtD
Alitretinoin—Hypersensitivity—Etoposide—germ cell cancer	3.46e-05	0.000455	CcSEcCtD
Alitretinoin—Erythema—Methotrexate—germ cell cancer	3.44e-05	0.000454	CcSEcCtD
Alitretinoin—Malnutrition—Methotrexate—germ cell cancer	3.44e-05	0.000454	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—H2AFZ—germ cell cancer	3.38e-05	0.000712	CbGpPWpGaD
Alitretinoin—Asthenia—Etoposide—germ cell cancer	3.37e-05	0.000443	CcSEcCtD
Alitretinoin—Back pain—Methotrexate—germ cell cancer	3.33e-05	0.000439	CcSEcCtD
Alitretinoin—Pruritus—Etoposide—germ cell cancer	3.32e-05	0.000437	CcSEcCtD
Alitretinoin—RARB—Gene Expression—H2AFZ—germ cell cancer	3.31e-05	0.000699	CbGpPWpGaD
Alitretinoin—ABCB1—brain—germ cell cancer	3.28e-05	0.000762	CbGeAlD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	3.27e-05	0.00069	CbGpPWpGaD
Alitretinoin—Vomiting—Cisplatin—germ cell cancer	3.26e-05	0.000429	CcSEcCtD
Alitretinoin—Vision blurred—Methotrexate—germ cell cancer	3.25e-05	0.000427	CcSEcCtD
Alitretinoin—Rash—Cisplatin—germ cell cancer	3.23e-05	0.000425	CcSEcCtD
Alitretinoin—Dermatitis—Cisplatin—germ cell cancer	3.23e-05	0.000425	CcSEcCtD
Alitretinoin—Diarrhoea—Etoposide—germ cell cancer	3.21e-05	0.000423	CcSEcCtD
Alitretinoin—Ill-defined disorder—Methotrexate—germ cell cancer	3.2e-05	0.000421	CcSEcCtD
Alitretinoin—Anaemia—Methotrexate—germ cell cancer	3.18e-05	0.000419	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—H2AFZ—germ cell cancer	3.17e-05	0.00067	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—H2AFZ—germ cell cancer	3.17e-05	0.00067	CbGpPWpGaD
Alitretinoin—ABCB1—lymph node—germ cell cancer	3.17e-05	0.000736	CbGeAlD
Alitretinoin—Malaise—Methotrexate—germ cell cancer	3.11e-05	0.000409	CcSEcCtD
Alitretinoin—Dizziness—Etoposide—germ cell cancer	3.1e-05	0.000409	CcSEcCtD
Alitretinoin—Nausea—Cisplatin—germ cell cancer	3.04e-05	0.000401	CcSEcCtD
Alitretinoin—Cough—Methotrexate—germ cell cancer	3.01e-05	0.000396	CcSEcCtD
Alitretinoin—Convulsion—Methotrexate—germ cell cancer	2.98e-05	0.000393	CcSEcCtD
Alitretinoin—Vomiting—Etoposide—germ cell cancer	2.98e-05	0.000393	CcSEcCtD
Alitretinoin—Rash—Etoposide—germ cell cancer	2.96e-05	0.00039	CcSEcCtD
Alitretinoin—Dermatitis—Etoposide—germ cell cancer	2.96e-05	0.000389	CcSEcCtD
Alitretinoin—Headache—Etoposide—germ cell cancer	2.94e-05	0.000387	CcSEcCtD
Alitretinoin—Chest pain—Methotrexate—germ cell cancer	2.93e-05	0.000386	CcSEcCtD
Alitretinoin—Arthralgia—Methotrexate—germ cell cancer	2.93e-05	0.000386	CcSEcCtD
Alitretinoin—Myalgia—Methotrexate—germ cell cancer	2.93e-05	0.000386	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	2.91e-05	0.000383	CcSEcCtD
Alitretinoin—Discomfort—Methotrexate—germ cell cancer	2.9e-05	0.000381	CcSEcCtD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	2.83e-05	0.000598	CbGpPWpGaD
Alitretinoin—Confusional state—Methotrexate—germ cell cancer	2.83e-05	0.000373	CcSEcCtD
Alitretinoin—Anaphylactic shock—Methotrexate—germ cell cancer	2.81e-05	0.00037	CcSEcCtD
Alitretinoin—Infection—Methotrexate—germ cell cancer	2.79e-05	0.000368	CcSEcCtD
Alitretinoin—Nausea—Etoposide—germ cell cancer	2.79e-05	0.000367	CcSEcCtD
Alitretinoin—Nervous system disorder—Methotrexate—germ cell cancer	2.76e-05	0.000363	CcSEcCtD
Alitretinoin—Thrombocytopenia—Methotrexate—germ cell cancer	2.75e-05	0.000362	CcSEcCtD
Alitretinoin—Skin disorder—Methotrexate—germ cell cancer	2.73e-05	0.00036	CcSEcCtD
Alitretinoin—Hyperhidrosis—Methotrexate—germ cell cancer	2.72e-05	0.000358	CcSEcCtD
Alitretinoin—Anorexia—Methotrexate—germ cell cancer	2.68e-05	0.000353	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—MYC—germ cell cancer	2.65e-05	0.000559	CbGpPWpGaD
Alitretinoin—Hypotension—Methotrexate—germ cell cancer	2.63e-05	0.000346	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	2.56e-05	0.000337	CcSEcCtD
Alitretinoin—Insomnia—Methotrexate—germ cell cancer	2.54e-05	0.000335	CcSEcCtD
Alitretinoin—Paraesthesia—Methotrexate—germ cell cancer	2.52e-05	0.000332	CcSEcCtD
Alitretinoin—RXRA—Metabolism—SLC2A3—germ cell cancer	2.51e-05	0.000529	CbGpPWpGaD
Alitretinoin—Dyspnoea—Methotrexate—germ cell cancer	2.51e-05	0.00033	CcSEcCtD
Alitretinoin—Somnolence—Methotrexate—germ cell cancer	2.5e-05	0.000329	CcSEcCtD
Alitretinoin—Dyspepsia—Methotrexate—germ cell cancer	2.47e-05	0.000326	CcSEcCtD
Alitretinoin—RXRA—Metabolism—SLC22A3—germ cell cancer	2.47e-05	0.000521	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—AVP—germ cell cancer	2.47e-05	0.000521	CbGpPWpGaD
Alitretinoin—Decreased appetite—Methotrexate—germ cell cancer	2.44e-05	0.000322	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Methotrexate—germ cell cancer	2.43e-05	0.00032	CcSEcCtD
Alitretinoin—Fatigue—Methotrexate—germ cell cancer	2.42e-05	0.000319	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—MYC—germ cell cancer	2.42e-05	0.000511	CbGpPWpGaD
Alitretinoin—Pain—Methotrexate—germ cell cancer	2.4e-05	0.000317	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.39e-05	0.000504	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	2.38e-05	0.000502	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—MYC—germ cell cancer	2.37e-05	0.000501	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Methotrexate—germ cell cancer	2.32e-05	0.000305	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methotrexate—germ cell cancer	2.3e-05	0.000303	CcSEcCtD
Alitretinoin—RARA—Generic Transcription Pathway—MYC—germ cell cancer	2.28e-05	0.000481	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MYC—germ cell cancer	2.28e-05	0.000481	CbGpPWpGaD
Alitretinoin—Urticaria—Methotrexate—germ cell cancer	2.23e-05	0.000294	CcSEcCtD
Alitretinoin—Abdominal pain—Methotrexate—germ cell cancer	2.22e-05	0.000293	CcSEcCtD
Alitretinoin—Body temperature increased—Methotrexate—germ cell cancer	2.22e-05	0.000293	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.14e-05	0.000452	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.11e-05	0.000445	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Methotrexate—germ cell cancer	2.07e-05	0.000273	CcSEcCtD
Alitretinoin—Asthenia—Methotrexate—germ cell cancer	2.02e-05	0.000266	CcSEcCtD
Alitretinoin—RXRA—Metabolism—CRABP1—germ cell cancer	2.01e-05	0.000425	CbGpPWpGaD
Alitretinoin—Pruritus—Methotrexate—germ cell cancer	1.99e-05	0.000262	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.96e-05	0.000414	CbGpPWpGaD
Alitretinoin—Diarrhoea—Methotrexate—germ cell cancer	1.92e-05	0.000253	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	1.87e-05	0.000395	CbGpPWpGaD
Alitretinoin—Dizziness—Methotrexate—germ cell cancer	1.86e-05	0.000245	CcSEcCtD
Alitretinoin—Vomiting—Methotrexate—germ cell cancer	1.79e-05	0.000235	CcSEcCtD
Alitretinoin—Rash—Methotrexate—germ cell cancer	1.77e-05	0.000233	CcSEcCtD
Alitretinoin—Dermatitis—Methotrexate—germ cell cancer	1.77e-05	0.000233	CcSEcCtD
Alitretinoin—Headache—Methotrexate—germ cell cancer	1.76e-05	0.000232	CcSEcCtD
Alitretinoin—Nausea—Methotrexate—germ cell cancer	1.67e-05	0.00022	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—H2AFZ—germ cell cancer	1.65e-05	0.000349	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.44e-05	0.000304	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MYC—germ cell cancer	1.27e-05	0.000269	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—germ cell cancer	1.19e-05	0.00025	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—germ cell cancer	1.17e-05	0.000246	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—germ cell cancer	1.14e-05	0.000241	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—germ cell cancer	1.1e-05	0.000231	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—germ cell cancer	1.1e-05	0.000231	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC2A3—germ cell cancer	1e-05	0.000211	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC22A3—germ cell cancer	9.87e-06	0.000208	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	9.87e-06	0.000208	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	9.55e-06	0.000201	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HRAS—germ cell cancer	8.77e-06	0.000185	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CRABP1—germ cell cancer	8.05e-06	0.00017	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC2A3—germ cell cancer	8e-06	0.000169	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC22A3—germ cell cancer	7.88e-06	0.000166	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	7.84e-06	0.000165	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CRABP1—germ cell cancer	6.42e-06	0.000136	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—germ cell cancer	5.71e-06	0.000121	CbGpPWpGaD
